| View |
2018-04-17-0064
|
Tetanus Toxoid Adsrobed Vaccine
|
T-Vac
|
BR-435
|
230L7021B
|
Packaging Lot: 230L7021B
|
30 November 2020
|
25 April 2018
|
| View |
2018-04-17-0065
|
Hepatitis B Vaccine (Recombinant DNA)
|
-
|
BR-589
|
033L7005
|
Packaging Lot (box and vial): 033L7005
|
30 November 2020
|
19 April 2018
|
| View |
2018-05-07-0083
|
Purified Vero Cell Rabies Vaccine
|
Abhayrab
|
BR-629
|
17URAB103
|
Packaging Lot: Box & Vial - 17URAB103; Diluent - SCSVBA0417 (MD - 10/17; ED - 09/21); Syringe w/ Needle - 1702503 (MD - 2017-02; ED - 2022-01)
|
30 November 2020
|
10 May 2018
|
| View |
2018-06-28-0135
|
Combined Hepatitis A & B Vaccine
|
Twinrix Adult
|
BR-404
|
AHABB388A
|
Packaging Lot: Box & PFS- AHABB388AF; Needle - 1701028 (ED: 2022-01-31)
|
30 November 2020
|
02 July 2018
|
| View |
2018-09-04-0192
|
LIVE ATTENUATED MEASLES AND RUBELLA VACCINE
|
-
|
BR-839
|
0098N001
|
Packaging Lot: 0098N001 (MD: JUN 2018, ED: NOV 2020); Diluent: 0648S1026Z (MD: APR 2018, ED: APR 2023)
|
30 November 2020
|
06 September 2018
|
| View |
2018-09-07-0195
|
Pneumococcal Conjugate Vaccine, 13-valent (adsorbed)
|
Prevenar 13
|
BR-898
|
W21477
|
Packaging Lot: Box & vials - X44729
|
30 November 2020
|
11 September 2018
|
| View |
2018-09-07-0196
|
Pneumococcal Conjugate Vaccine, 13-valent (adsorbed)
|
Prevenar 13
|
BR-898
|
W21479
|
Packaging Lot: Box & vials - X44732
|
30 November 2020
|
11 September 2018
|
| View |
2018-09-13-0201
|
Pneumococcal Conjugate Vaccine, 13-valent (adsorbed)
|
Prevenar 13
|
BR-898
|
W21478
|
Packaging Lot: Box & vials - X44731, MD: 12/2017, ED: 11/2020
|
30 November 2020
|
25 September 2018
|
| View |
2018-09-13-0202
|
Pneumococcal Conjugate Vaccine, 13-valent (adsorbed)
|
Prevenar 13
|
BR-898
|
W18208
|
Packaging Lot: Box & vials - X44730
|
30 November 2020
|
17 September 2018
|
| View |
2018-10-12-0229
|
Pneumococcal Conjugate Vaccine, 13-valent (Adsorbed)
|
Prevenar 13
|
BR-898
|
X59979 (W21476)
|
Packaging Lot: Box & vials - X59979, MD: 12/2017, ED: 11/2020
|
30 November 2020
|
17 October 2018
|
| View |
2018-10-12-0232
|
Pneumococcal Conjugate Vaccine, 13-valent (adsorbed)
|
Prevenar 13
|
BR-898
|
X59977 (W21475)
|
Packaging Lot: Box & vials - X59977; MD: 12/2017; ED: 11/2020
|
30 November 2020
|
17 October 2018
|
| View |
2018-10-19-0239
|
Live Attenuated Rotavirus Vaccine
|
Rotarix
|
BR-674
|
AROLC131A
|
Packaging Lot: Box & PFS - AROLC131AI
|
30 November 2020
|
23 October 2018
|
| View |
2018-12-06-0281
|
Hepatitis B (rDNA) Vaccine
|
Engerix-B
|
BR-254
|
AHBVC716A
|
Packaging Lot (box and vial): AHBVC716AC
|
30 November 2020
|
12 December 2018
|
| View |
2019-01-23-0012
|
Purified Vero Cell Rabies Vaccine
|
Abhayrab
|
BR-629
|
17URAB103
|
Packaging Lot: Box & Vial - 17URAB103; Diluent - SCSVBA0417 (MD - 10/17; ED - 09/21); Syringe w/ Needle - 1702503 (MD - 2017-02; ED - 2022-01)
|
30 November 2020
|
28 January 2019
|
| View |
2019-05-08-0095
|
Rabies Vaccine for Human Use (Purified Chick Embryo Cell)
|
Vaxirab N
|
BRP-071
|
RV80018
|
Packaging lot-Box & Vial: RV80018, MD: DEC.18, ED: NOV.20; Diluent: AMU1001, MD: NOV.2018, ED: OCT.2023
|
30 November 2020
|
10 May 2019
|
| View |
2019-08-01-0175
|
Live Attenuated Varicella-Zoster Virus Vaccine
|
V-Z Vax
|
BR-388
|
S50118050
|
Packaging lot: Box & vial: S50118050; Diluent lot: S70218033, MD 04.10.2018, ED 03.10.2021
|
30 November 2020
|
06 August 2019
|
| View |
2019-05-20-0101
|
Tetanus Toxoid (Adsorbed)
|
T-Vac
|
BR-326
|
2598A005B
|
Packaging lot (box and ampoule): 2598A005B
|
30 November 2021
|
22 May 2019
|
| View |
2019-06-07-0122
|
Tetanus Toxoid (Adsorbed)
|
T-Vac
|
BR-326
|
2598A005E
|
Packaging Lot: Box & Vial: 2598A005E
|
30 November 2021
|
13 June 2019
|
| View |
2019-07-01-0144
|
Tetanus Toxoid (Adsorbed)
|
T-Vac
|
BR-326
|
2598A005F
|
Packaging Lot (box & ampoule) : 2598A005F
|
30 November 2021
|
04 July 2019
|
| View |
2019-10-25-0272
|
Inactivated Poliomyelitis Vaccine (Types 1, 2 and 3)
|
Imovax Polio
|
BR-929
|
R3N29
|
Packaging Lot - Box: R3N291V; Vial: R3N29, MD: 01122018, ED: 11-2021
|
30 November 2021
|
30 October 2019
|